Bradrick Brittany bought DRMA
January 2, 2026 · Form 4 insider transaction
Bradrick Brittany bought 2,500 shares of Dermata Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,500
Price
$0.00
Total value
N/A
InsiderBradrick Brittany
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after2,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying the option will vest in a series of twelve (12) successive substantially equal monthly installments, with the first installment vesting on the one month anniversary of the grant date and continuing to vest monthly thereafter, subject to Reporting Person's continuous service through each such vesting date.